These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1406 related articles for article (PubMed ID: 25482613)

  • 21. Icariin Regulates EMT and Stem Cell-Like Character in Breast Cancer through Modulating lncRNA NEAT1/TGFβ/SMAD2 Signaling Pathway.
    Song B; Wei F; Peng J; Wei X; Liu M; Nie Z; Ma Y; Peng T
    Biol Pharm Bull; 2024 Feb; 47(2):399-410. PubMed ID: 38220208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells.
    Sengupta S; Jana S; Bhattacharyya A
    Cell Signal; 2014 Feb; 26(2):240-52. PubMed ID: 24269534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased eIF3e Expression Can Mediate Epithelial-to-Mesenchymal Transition through Activation of the TGFβ Signaling Pathway.
    Desnoyers G; Frost LD; Courteau L; Wall ML; Lewis SM
    Mol Cancer Res; 2015 Oct; 13(10):1421-30. PubMed ID: 26056130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancer Reprogramming within Pre-existing Topologically Associated Domains Promotes TGF-β-Induced EMT and Cancer Metastasis.
    Qiao Y; Wang Z; Tan F; Chen J; Lin J; Yang J; Li H; Wang X; Sali A; Zhang L; Zhong G
    Mol Ther; 2020 Sep; 28(9):2083-2095. PubMed ID: 32526202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways.
    Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S
    J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells.
    Yu J; Lei R; Zhuang X; Li X; Li G; Lev S; Segura MF; Zhang X; Hu G
    Nat Commun; 2016 Dec; 7():13884. PubMed ID: 27996004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mnt Represses Epithelial Identity To Promote Epithelial-to-Mesenchymal Transition.
    Lavin DP; Abassi L; Inayatullah M; Tiwari VK
    Mol Cell Biol; 2021 Oct; 41(11):e0018321. PubMed ID: 34460331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.
    Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Joven J; Menendez JA
    Cell Cycle; 2010 Nov; 9(22):4461-8. PubMed ID: 21088486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TGFβ selects for pro-stemness over pro-invasive phenotypes during cancer cell epithelial-mesenchymal transition.
    Tsubakihara Y; Ohata Y; Okita Y; Younis S; Eriksson J; Sellin ME; Ren J; Ten Dijke P; Miyazono K; Hikita A; Imamura T; Kato M; Heldin CH; Moustakas A
    Mol Oncol; 2022 Jun; 16(12):2330-2354. PubMed ID: 35348275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition.
    Xu W; Yang Z; Lu N
    Cell Adh Migr; 2015; 9(4):317-24. PubMed ID: 26241004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
    Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
    Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta-induced epithelial-mesenchymal transition in the lens: a model for cataract formation.
    de Iongh RU; Wederell E; Lovicu FJ; McAvoy JW
    Cells Tissues Organs; 2005; 179(1-2):43-55. PubMed ID: 15942192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor β signaling regulates the invasiveness of normal mammary epithelial cells and the metastasis formation of tumor cells.
    Vafaizadeh V; Graab U; Darvishi T; Machado R; Groner B
    Horm Mol Biol Clin Investig; 2012 Jun; 10(1):227-39. PubMed ID: 25436679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
    Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
    Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Atypical System for Studying Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.
    Vedagiri D; Lashkari HV; Mangani AS; Kumar JM; Jose J; Thatipalli AR; Harshan KH
    Sci Rep; 2016 May; 6():26282. PubMed ID: 27197891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing the BMP signaling pathway to control the formation of cancer stem cells by effects on epithelial-to-mesenchymal transition.
    Bosukonda A; Carlson WD
    Biochem Soc Trans; 2017 Feb; 45(1):223-228. PubMed ID: 28202676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression.
    Ren J; Smid M; Iaria J; Salvatori DCF; van Dam H; Zhu HJ; Martens JWM; Ten Dijke P
    Breast Cancer Res; 2019 Sep; 21(1):109. PubMed ID: 31533776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "good-cop bad-cop" TGF-beta role in breast cancer modulated by non-coding RNAs.
    Gulei D; Mehterov N; Ling H; Stanta G; Braicu C; Berindan-Neagoe I
    Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1661-1675. PubMed ID: 28411077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occurrence and significance of epithelial-mesenchymal transition in breast cancer.
    Roxanis I
    J Clin Pathol; 2013 Jun; 66(6):517-21. PubMed ID: 23322823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
    Tan AR; Alexe G; Reiss M
    Breast Cancer Res Treat; 2009 Jun; 115(3):453-95. PubMed ID: 18841463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.